Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017 (2017), Article ID 1839190, 5 pages
https://doi.org/10.1155/2017/1839190
Research Article

Epidemiology and Genetic Diversity of Colistin Nonsusceptible Nosocomial Acinetobacter baumannii Strains from Russia for 2013-2014

Institute of Antimicrobial Chemotherapy (IAC), Smolensk State Medical University (SSMU), Kirova St. 46a, Smolensk 214019, Russia

Correspondence should be addressed to Eugene A. Sheck; ur.citoibitna@kcehs.yinegve

Received 29 June 2017; Accepted 13 September 2017; Published 17 October 2017

Academic Editor: Branka Bedenić

Copyright © 2017 Eugene A. Sheck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Dijkshoorn, A. Nemec, and H. Seifert, “An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii,” Nature Reviews Microbiology, vol. 5, no. 12, pp. 939–951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kempf and J.-M. Rolain, “Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: Clinical impact and therapeutic options,” International Journal of Antimicrobial Agents, vol. 39, no. 2, pp. 105–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Bonnin, P. Nordmann, and L. Poirel, “Screening and deciphering antibiotic resistance in Acinetobacter baumannii: A state of the art,” Expert Review of Anti-infective Therapy, vol. 11, no. 6, pp. 571–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L. C. S. Antunes, P. Visca, and K. J. Towner, “Acinetobacter baumannii: evolution of a global pathogen,” Pathogens and Disease, vol. 71, no. 3, pp. 292–301, 2014. View at Publisher · View at Google Scholar
  5. European Centre for Disease Prevention and Control, “Antimicrobial resistance surveillance in Europe 2015,” Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net), European Centre for Disease ECDC, Stockholm, Sweden, 2017. View at Google Scholar
  6. I. Karaiskos and H. Giamarellou, “Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches,” Expert Opinion on Pharmacotherapy, vol. 15, no. 10, pp. 1351–1370, 2014. View at Publisher · View at Google Scholar
  7. I. Karaiskos, M. Souli, I. Galani, and H. Giamarellou, “Colistin: still a lifesaver for the 21st century?” Expert Opinion on Drug Metabolism & Toxicology, vol. 13, no. 1, pp. 59–71, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Jeannot, A. Bolard, and P. Plésiat, “Resistance to polymyxins in Gram-negative organisms,” International Journal of Antimicrobial Agents, vol. 49, no. 5, pp. 526–535, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Cai, D. Chai, R. Wang, B. Liang, and N. Bai, “Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 7, pp. 1607–1615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Karah, A. Sundsfjord, K. Towner, and Ø. Samuelsen, “Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii,” Drug Resistance Updates, vol. 15, no. 4, pp. 237–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Zarrilli, S. Pournaras, M. Giannouli, and A. Tsakris, “Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages,” International Journal of Antimicrobial Agents, vol. 41, no. 1, pp. 11–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. V. Sukhorukova, M. V. Edelstein, E. Yu. Skleenova et al., “Antimicrobial resistance of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014,” Clinical Microbiology and Antimicrobial Chemotherapy, vol. 19, no. 1, pp. 42–48, 2017. View at Google Scholar
  13. ISO 20776-1:2006, “Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1 : Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases”.
  14. European Committee on Antimicrobial Susceptibility testing (EUCAST), “Breakpoint tables for interpretation of MICs and zone diameters,” Ver. 7.1, 2017, http://www.eucast.org/clinical_breakpoints/.
  15. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement, CLSI document M100-S17, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2011, http://clsi.org/m100/. View at Publisher · View at Google Scholar
  16. S. Pournaras, V. Koumaki, V. Gennimata, E. Kouskouni, and A. Tsakris, “In vitro activity of tigecycline against Acinetobacter baumannii: Global epidemiology and resistance mechanisms,” Advances in Experimental Medicine and Biology, vol. 897, pp. 1–14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Sheck, A. Fedintsev, E. Skleenova, A. Martinovich, and M. Edelstein, “Development of a high-throughput single nucleotide polymorphism typing method for Acinetobacter baumannii (SNPTAb,” in Proceedings of the P0079, 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, pp. 25–28, 2015.
  18. A. Fedintsev, E. Sheck, A. Avramenko, I. Trushin, and M. Edelstein, “Development of an online database and web application for analysis of SNP typing data of Acinetobacter baumannii EP0313,” in Proceedings of the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), vol. 38, ESCMID, Amsterdam, Netherlands, April 2016. View at Publisher · View at Google Scholar
  19. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Giannouli, S. Cuccurullo, V. Crivaro et al., “Molecular epidemiology of multidrug-resistant acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1223–1230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Giannouli, L. C. S. Antunes, V. Marchetti, M. Triassi, P. Visca, and R. Zarrilli, “Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78,” BMC Infectious Diseases, vol. 13, no. 1, article no. 282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. L. S. Munoz-Price, K. Arheart, P. Nordmann et al., “Eighteen years of experience with acinetobacter baumannii in a tertiary care hospital*,” Critical Care Medicine, vol. 41, no. 12, pp. 2733–2742, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Pfeifer, K.-P. Hunfeld, S. Borgmann et al., “Carbapenem-resistant Acinetobacter baumannii ST78 with OXA-72 carbapenemase and ESBL gene blaCTX-M-115,” Journal of Antimicrobial Chemotherapy, vol. 71, no. 5, Article ID dkv462, pp. 1426–1432, 2016. View at Publisher · View at Google Scholar · View at Scopus